Gene · 6428
Papers2,106
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,106
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of alternative pre-mRNA splicing in cancer progression. | Cancer Cell Int | 2023 | 37875914 | PubTator, text mining | PubMed |
| RNA sequestration driven by amyloid formation: the alpha synuclein case. | Nucleic Acids Res | 2023 | 37870427 | PubTator, text mining | PubMed |
| m6A reading protein RBMX as a biomarker for prognosis and tumor progression in esophageal cancer. | Transl Cancer Res | 2023 | 37859733 | PubTator, text mining | PubMed |
| Crosstalk between m6A modification and alternative splicing during cancer progression. | Clin Transl Med | 2023 | 37850412 | PubTator, text mining | PubMed |
| Aspartyl-tRNA synthetase 2 orchestrates iron-sulfur metabolism in hematopoietic stem cells via fine-tuning alternative RNA splicing. | Cell Rep | 2023 | 37838946 | PubTator, text mining | PubMed |
| The Role of the Dysregulation of Long Non-Coding and Circular RNA Expression in Medulloblastoma: A Systematic Review. | Cancers (Basel) | 2023 | 37835380 | PubTator, text mining | PubMed |
| Insulin Receptor Isoforms and Insulin Growth Factor-like Receptors: Implications in Cell Signaling, Carcinogenesis, and Chemoresistance. | Int J Mol Sci | 2023 | 37834454 | PubTator, text mining | PubMed |
| N6-methyladenosine modification-a key player in viral infection. | Cell Mol Biol Lett | 2023 | 37828480 | PubTator, text mining | PubMed |
| Downregulation of apoptotic repressor AVEN exacerbates cardiac injury after myocardial infarction. | Proc Natl Acad Sci U S A | 2023 | 37816050 | PubTator, text mining | PubMed |
| An Improved Model for Circular RNA Overexpression: Using the Actin Intron Reveals High Circularization Efficiency. | Adv Genet (Hoboken) | 2023 | 37766804 | PubTator, text mining | PubMed |
| LincRNA-P21 knockdown facilitates esophageal squamous cell carcinoma cell progression by upregulating cadherin 5 via YTH domain containing 1. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37766459 | PubTator, text mining | PubMed |
| FOXM1a Isoform of Oncogene FOXM1 Is a Tumor Suppressor Suppressed by hnRNP C in Oral Squamous Cell Carcinoma. | Biomolecules | 2023 | 37759731 | PubTator, text mining | PubMed |
| Identification of two short peptide motifs from serine/arginine-rich protein ribonucleic acid recognition motif-1 domain acting as splicing regulators. | PeerJ | 2023 | 37744237 | PubTator, text mining | PubMed |
| Splicing regulation of GFPT1 muscle-specific isoform and its roles in glucose metabolisms and neuromuscular junction. | iScience | 2023 | 37744035 | PubTator, text mining | PubMed |
| Interaction between N6-methyladenosine modification and the tumor microenvironment in colorectal cancer. | Mol Med | 2023 | 37737134 | PubTator, text mining | PubMed |
| On a path toward a broad-spectrum anti-viral: inhibition of HIV-1 and coronavirus replication by SR kinase inhibitor harmine. | J Virol | 2023 | 37706687 | PubTator, text mining | PubMed |
| Combining old and new concepts in targeting telomerase for cancer therapy: transient, immediate, complete and combinatory attack (TICCA). | Cancer Cell Int | 2023 | 37679807 | PubTator, text mining | PubMed |
| The master energy homeostasis regulator PGC-1α exhibits an mRNA nuclear export function. | Nat Commun | 2023 | 37679383 | PubTator, text mining | PubMed |
| Targeted splicing therapy: new strategies for colorectal cancer. | Front Oncol | 2023 | 37664052 | PubTator, text mining | PubMed |
| Towards understandings of serine/arginine-rich splicing factors. | Acta Pharm Sin B | 2023 | 37655328 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6428/papers?page=9